Abstract: Coarse Structural Nested Mean Models (SNMMs, Robins, 2000) and G-estimation can be used to estimate the causal effect of a time-varying treatment from longitudinal observational studies. However, they rely on an untestable assumption of no unmeasured confounding. In the presence of unmeasured confounders, the unobserved potential outcomes are not missing at random, and standard G-estimation leads to biased effect estimates. To remedy this, we investigate the sensitivity of G-estimators of coarse SNMMs to unmeasured confounding, assuming a nonidentifiable bias function which quantifies the impact of unmeasured confounding on the average potential outcome. We present adjusted G-estimators of coarse SNMM parameters and prove their consistency, under the bias modeling for unmeasured confounding. We apply this to a sensitivity analysis for the effect of the ART initiation time on the mean CD4 count at year 2 after infection in HIV-positive patients, based on the prospective Acute and Early Disease Research Program.
Introduction
Randomized control trials have been regarded as the gold standard for treatment comparison; however, they may not be feasible due to ethical issues, cost restrictions, implementation difficulty, etcetera. In such cases, observational studies can be useful. Since individuals are not randomly assigned to treatments, the observed association between treatment and outcome may be due to the confounders that predict both treatment assignment and outcome. Therefore, it is important to control for all the confounders in order to obtain a valid causal conclusion about the treatment effect.
We consider the potential outcome framework (Rubin, 1974; Robins et al., 1992) , which has been commonly adopted in the causal inference literature. For illustration, consider a single-time-point setting where we have pre-treatment variables L, a binary treatment A with 0 indicating the control treatment and 1 indicating the active treatment, and lastly an outcome at the end of the study, Y . In this setting, each patient has two potential outcomes: Y (0) , the outcome that would be realized if the patient received the control treatment, and Y
(1) , the outcome that would be realized if the patient received the active treatment. We assume that the observed outcome is equal to the potential outcome under the actual treatment, i.e., Y = Y (A) (the consistency assumption, Rubin, 1974) . Therefore, causal inference can be conceptualized as a missing data problem in which only one potential outcome is observed for each patient. Rubin (1974) described the condition for estimating average causal effects in this setting, which assumes that there is no unmeasured confounders, i.e.,
for a = 0, 1. Under (1.1), the potential outcomes are missing at random (Rubin, 1976) and the selection bias can be removed by adjusting for the measured covariates. However, if there are unmeasured confounders, the potential outcomes are not missing at random conditional on the measured covariates, which renders the effect estimates to be unidentifiable. For observational studies with a time-varying treatment, Robins (1986; 1987) established the conditions for estimating causal effects, and proposed two classes of models: Marginal Structural Models (MSMs, Robins, 2000) and SNMMs (Robins, 1994 (Robins, , 2000 Lok et al., 2004; Lok, Hérnan and Robins, 2007) , which adjust for selection bias due to measured time-varying confounders. In a recent assessment of the dependence of the effect of ART on its initiation time, Lok and DeGruttola (2012) developed a new class of coarse SNMMs and applied it to the observational AIEDRP (Acute Infection and Early Disease Research Program) database. The validity of G-estimation of the SNMMs analyses relies on two key assumptions: (i) the treatment effect model is well-specified, and (ii) there are no unmeasured treatment-outcome confounders. In practice, both assumptions are rather strong and can be violated. Yang and Lok (2016) developed a goodnessof-fit test procedure to assess the model fit (assumption (i)). This paper addresses sensitivity to unmeasured confounding (assumption (ii)).
The existing literature on sensitivity analyses to unmeasured confounders is large, including Schlesselman (1978) , Lin, Psaty and Kronmal (1998) , Greenland (2003 Greenland ( , 2005 , McCandless, Gustafson and Levy (2007) , Cornfield et al. (2009), and Rosenbaum (2009) . Cornfield et al. (2009) used sensitivity analyses formally to assess the association between smoking and lung cancer; Rosenbaum (2009) has done extensive modeling of how unmeasured confounders affect the treatment assignment and outcome; and McCandless, Gustafson and Levy (2007) proposed a Bayesian approach to conducting sensitivity analyses where the prior distribution models beliefs about unknown and unmeasured confounding. However, many existing methods are limited to simple settings, e.g., most of these works consider settings with a single time-point treatment, or rely on external sources of information on the unmeasured confounders. In a longitudinal setting with time-dependent treatments, the literature is scarce. The exceptions include Robins, Rotnitzky and Scharfstein (2000) and Brumback et al. (2004) . Brumback et al. (2004) implemented a sensitivity analysis to unmeasured confounding of inverse-probability-of-treatment-weighting estimators for MSMs. SNMMs have more desirable features than MSMs (Robins, 2000) , for example, (i) SNMMs do not require the positivity assumption which assumes the probability of all patients receiving each treatment regimen is positivity, which may be questionable in practice; (ii) SNMMs can handle continuous-valued treatments, but MSMs can not; (iii) SNMMs are able to model time-varying interaction between covariates and treatment in the outcome model. Despite these advantages, their applications in practice are unfortunately still limited (Vansteelandt and Joffe, 2014) . Therefore, we aim to provide a suitable methodology to deal with unmeasured confounding for SNMMs, so as to promote SNMMs in practice.
As in the single-time-point setting, in the presence of unmeasured confounders, the unobserved potential outcomes are not missing at random, and standard G-estimation lead to biased effect estimates. In this paper, we investigate the sensitivity of G-estimation of coarse SNMMs to unmeasured confounding, assuming a nonidentifiable bias function quantifying the impact of unmeasured confounding on the average potential outcome. We propose adjusted G-estimators of coarse SNMMs parameters and prove their consistency, under the bias modeling for unmeasured confounding. In section 2, we present the motivating data set and coarse SNMMs analysis. In section 3, we present the sensitivity analysis for coarse SNMMs in a time-varying treatment setting. In section 4, we present the inverseprobability-of-censoring-weighting technique to accommodate patients loss to follow up. In section 5, we apply the proposed method to the motivating data set. Section 6 concludes.
Coarse Structural Nested Mean Models

The AIEDRP dataset
ART (Antiretroviral Treatment) is a standard initial treatment for HIVStatistica Sinica: Newly accepted Paper (accepted version subject to English editing) positive patients, and has considerably reduced the morbidity and mortality in HIV-positive patients. However, there is no strong evidence to support when to start ART in patients in the acute and early stages of infection. For this investigation, we use the observational AIEDRP (Acute Infection and Early Disease Research Program), which consists of 1762 HIV-positive patients diagnosed during acute and early infection (Hecht et al., 2006) . Dates of infection were estimated based on a stepwise algorithm using clinical and laboratory data (Hecht et al., 2006; Smith et al., 2006) . Lok and DeGruttola (2012) explored this data set and argued that the data show time-varying confounding by indication, and applied coarse SNMMs to estimate how the time between infection and ART initiation affects the effect of one year of ART on immune reconstitution as measured by CD4 count. They adjusted for selection bias due to observed time-varying confounders. Their analysis showed that ART is beneficial in acute and early infection, with a possible increased beneficial effect of earlier ART initiation. Although several measured confounders, including age, gender, race, injection drug use, CD4 count and viral load, were considered in this analysis, the adjusted effect estimate may be biased due to unmeasured confounders. For example, psychosocial factors (Villes et al., 2007) and comorbidities (Abara et al., 2014) are important confounders of the association between the ART initiation time and the CD4 count outcome. Unfortunately, these confounders were not available.
We aim to estimate the averaged causal relationship between the ART initiation time and the mean CD4 counts two years after infection. We will adjust for both measured confounders and possibly unmeasured confounding. To do this, we will use sensitivity analyses to estimate the potential impact of unmeasured confounders on the estimated causal parameters.
Data Structure
Suppose all participants, in a random sample of size n, are followed monthly at months 0, . . . , K + 1, where 0 is the estimated date of infection, and K + 1 is the last month of interest (month 24 in our application). For each individual, we observed a treatment regimen (A 0 , . . . , A K ) with A k the treatment determined at month k, and a covariate process (L 0 , . . . , L K+1 ). A k = 1 if the treatment is started at month k and 0 otherwise, and L k is a set of observed covariates at month k, which is measured after A k−1 and before A k . The data are represented as n i.
, where we use overbars to denote the histories of time-dependent treatments and covariates. and for notational simplicity we drop the subscript i for patients. We denote the outcome of interest with Y and we have Y = L K+1 , the CD4 count measured at the end of the study. We assume that treatment is monotone in the sense that once the treatment is initiated, it never stops under followup. Thus, the treatment regimen is determined by the treatment initiation time m. Let T be the actual month of treatment initiation. If treatment was never initiated during the study period, let T = ∞.
The potential outcomes
Let Y (∞) be the outcome CD4 count at month K + 1 after infection had the patient never initiated treatment. This is a counterfactual outcome. It is only observed if the patient did not initiate the treatment. Let Y (m) be the CD4 count at month K + 1 had the patient started treatment at month m. Under this potential outcome framework, we need the consistency assumption, which links the counterfactual data to the observed data, i.e., Y = Y (T ) .
Coarse SNMMs
Following Robins (2000) and Lok and DeGruttola (2012) , we define the treatment effect model as conditional treatment contrasts, for 0 ≤ m ≤ K,
We assume a parametric model for γ, γ m,ψ (l m ) = (ψ 0 + ψ 1 m)(K + 1 − m), since arguably the average treatment effect is proportional to the treatment duration (K + 1 − m), and the coefficients can depend on the treatment initiation time m. If ψ 0 + ψ 1 m > 0 and ψ 1 < 0, the treatment is beneficial with increased gain if it was started earlier.
The conditional probabilities of treatment initiation
Unlike in randomized control trials, the treatment assignment mechanism is unknown in observational studies. We assume that we have a correctly specified parametric model for treatment initiation given the observed covariate history:
This could be a pooled logistic regression model. Since treatment is monotone, P r(A m = 1 |L m , A m−1 = 1) = 1.
G-estimation under no unmeasured confounding
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The parameters in γ ψ can not be estimated by regression methods since the dependent variable involves the potential outcome. For parameter identification, we require the assumption of no unmeasured confounding (Robins et al., 1992; Robins, 2000) :
where A B means "A is independent of B" (Dawid, 1979) . To facilitate estimation, define
which mimics the potential outcome Y (∞) since by blipping off the average treatment effect from the observed outcome, we would obtain a quantity that has the same conditional distribution as the outcome that would have been observed (Lok and DeGruttola, 2012) :
where by convention,
2) does not require (2.4). Together, (2.2) and (2.4) imply that
which is the key behind estimation. G-estimators solves unbiased estimating equations constructed based on (2.5) (Robins et al., 1992; Robins, 1994 Robins, , 2000 Lok and DeGruttola, 2012) .
Evaluating the impact of unmeasured confounding
Assumption (2.2) can not be tested empirically from the data. If this assumption fails, the treatment assignment is non-ignorable or, equivalently, there is selection bias on unmeasured confounders. For 0 ≤ m ≤ K, define the selection bias function due to unmeasured confounders (Robins, Rotnitzky and Scharfstein, 2000) as The observed data carry no information about selection bias on unmeasured confounders: is it present? If it is present, in which direction does it bias the result? How large is the magnitude? While these questions are important for modeling, the data at hand cannot provide such answers. In other words, the selection bias on unmeasured confounders can never be inferred from the data, rather its form should be pre-specified based on the modeler's belief, and its magnitude should be explored in a wide range in the sensitivity analysis. Let g(L m ; η) be a correct model of g(L m ), where η is regarded as the sensitivity parameter. We parametrize g so that g(L m ; 0) = 0, so that η = 0 indicates there is no unmeasured confounders. The functional form of the nuisance models can be selected on the basis of the observed data, as well as the literature and subject knowledge specific to the application setting. Later in this article, we provide a more specific illustration in the context of our example. Equation (2.5) is the key for estimation under the assumption of No Unmeasured Confounders. Now since this assumption does not necessarily hold, (2.5) is not necessarily true. But we would like to adjust the previously defined mimicking outcome H ψ so that a similar relationship to (2.5) holds for the adjustments.
The superscript "a" stands for the adjustment. In the Appendix, we show the following result, which replaces the role of (2.5) for estimation. Theorem 1. Under the Consistency assumption, assuming γ ψ is a correctly specified model for the treatment effect γ, g(L m , A m ; η) is a correctly specified selection bias function due to unmeasured confounding with predetermined value for η, and let H a m be the adjusted mimicking outcome in
Theorem 2 (Unbiased Estimating Equation Under Unmeasured Confounding). Under the Consistency assumption, assuming γ ψ is a correct model for the treatment effect γ, g(L m ,Ā m ; η) is a correctly-specified selection bias function due to unmeasured confounding with pre-determined value for η, and let H a m be the adjusted mimicking outcome in (3.1). Then, the following estimating function
is an unbiased estimating equation for any q(L m ).
The proof of Theorem 2 is given in the Appendix. Theorem 2 leads to a large number of unbiased estimating equations for ψ. To facilitate optimal estimation, we identify the optimal set of q, q opt , which satisfies
for any q. With this q opt , the resulting estimator from (3.3) is most efficient among the class (Newey and McFadden, 1994) .
where H ψ is defined in (2.3) and H a m,(ψ,η) is defined in (3.1). Proof of Theorem 3 is given in the Appendix. The assumption that E{H a m,(ψ,η) H a l,(ψ,η) |L m ,Ā m } does not depend on A m for 0 ≤ l ≤ m ≤ K is an organic extension of (3.2). This assumption does not affect the consistency of the estimator, but the efficiency. Remark 1. Estimating equations (3.3) with (3.6) are not well posed for estimation so far since they involve unknown population quantities through
does not depend on ψ; however, they Statistica Sinica: Newly accepted Paper (accepted version subject to English editing) still depend on the true unknown distribution to compute the conditional expectations. To obtain estimators with good efficiency properties we will approximate the unknown functions with estimators of them under some working model. Specifically, we propose the following algorithm: (i) obtain a consistent preliminary estimator of ψ, denoted byψ p ; (ii) approximate E(∂H ψ /∂ψ |L m ,Ā m ) by regression models E(∂H ψ /∂ψ |L m ,Ā m ;ξ), wherê ξ is the estimated parameters in the regression models; (iii) approximate
; and (iv) replace nuisance regression outcome models with estimators of them under the regression models and solve the resulting estimating equation for ψ. The resulting estimator is locally optimal under these nuisance regression outcome models. The 95% bootstrap confidence intervals ofψ can be constructed using the 2.5% and 97.5% percentiles of the 500 bootstrap realizations ofψ.
Remark 2 (Double robustness). In the estimating equations (3.3), the true treatment initiation model is unknown. We will replace it with P r(A m = 1 |L m ,Ā m−1 =0;α), whereα is the maximum likelihood estimator of α. The resulting estimator of ψ solving the estimating equations (3.3) with this replacement is equivalent to the estimator of ψ solving the estimating equations (3.3) and the estimating equation for α. Although (3.3) depends on two sets of nuisance models, E(H a m,(ψ,η) |L m ,Ā m−1 =0; ξ) and P r(A m = 1 |L m ,Ā m−1 =0; α), it does not require both specifications to be correct, which renders the estimator to be doubly robust. See the Appendix for the proof.
Censoring
Because of the time-dependent nature of longitudinal data, the data are often subject to censoring due to loss to follow up. When the censoring mechanism is informative in the sense that censoring may depend on timevarying covariates, e.g. sicker patients drop out of the study with higher probability than healthier patients, the patients remaining in the study are a biased sample of the full population.
Following Robins, Rotnitzky and Zhao (1995) and Lok and DeGruttola (2012) , we use inverse probability of censoring weighting (IPCW) to accommodate patients lost to follow up. We assume that the censoring process is ignorable in the sense that censoring only depends on the past observed covariate history but not the future unobserved covariates and outcomes. Its heuristic idea is to redistribute the weight of censored patients among the "similar" remaining uncensored patients. Let C m be the censoring indicator at month m, i.e. C m = 1 if the patient is censored at month m and 0 otherwise. We assume a parametric model for the censoring process given the observed covariates history to be P r(C m+1 = 0 |L m ,Ā m−1 , C m = 0) = P r(C m+1 = 0 |L m ,Ā m−1 , C m = 0; β), e.g. a pooled logistic regression model.
Define the IPCW version of estimating functions as
is an unbiased estimating equation if the censoring model is correct.
Application to Initiating ART in HIV-Positive Patients
We conducted a sensitivity analysis of estimating the effect of ART initiation time on mean CD4 count at year 2 after estimated date of infection in HIV-positive patients, based on the AIEDRP database described in Section .
We considered the true treatment effect model to be γ m,ψ (l m ) = (ψ 1 + ψ 2 m)(K + 1 − m). Yang and Lok (2016) showed that this model may be adequate using an overidentification restrictions test. In the estimation procedure, the treatment initiation model and the censoring model were fitted by pooled logistic regression models, and the nuisance regression outcome models were fitted by linear models, adjusting for a rich set of covariates based on the HIV literature and clinical knowledge (Lok and Griner, 2014) .
In the sensitivity analysis, we considered three scenarios for specification of g(L m ; η): (i) η 0 ; (ii) η 0 + η 1 × m; and (iii) η 0 + η 1 × CD4 m . Table 1 shows the results of the sensitivity analysis. In scenario (i), g(L m ; η) = η 0 with η 0 ∈ {−100, −75, . . . , 75, 100}. For interpretation, for example, with η 0 < 0, the untreated individuals tend to be healthier than the treated at month m, uniformly across months, even after controlling for measured confounders. As the magnitude of η increases,ψ 1 andψ 2 increase, which makes sense since the more the uncontrolled confounding is assumed, the further the adjusted estimator increases. Moreover, the confidence intervals ofψ 1 andψ 2 are larger with larger η, which suggests that more unmeasured confounding would further obscure the treatment effect. In scenario (ii), g(L m ; η) = η 0 + η 1 × m, i.e. the effect of uncontrolled confounding changes linearly with m. We considered η 0 ∈ {−100, −75, . . . , 75, 100} and η 2 ∈ {−5, 5}. For interpretation, consider for example g(L m ; η) = −100 − 5m, the untreated individuals tend to be healthier than the treated at month m, and the effect of uncontrolled confounding increases with m. For η 2 = 5, as η 1 increases from −100 to 100,ψ 1 andψ 2 decrease, andψ 2 remains negative but statistically insignificant. For η 2 = −5, as η 1 increases from −100 to 100,ψ 1 andψ 2 decrease, andψ 2 remains positive but statistically insignificant. In scenarios (iii), g(L m ; η) = η 0 + η 1 × CD4 m , i.e. the effect of uncontrolled confounding changes linearly with CD4. We considered η 0 ∈ {−100, −75, . . . , 75, 100} and η 2 ∈ {−0.02, 0.02}. As η 1 increases from −100 to 100,ψ 1 andψ 2 decrease.ψ 2 remains negative; however, the 95% bootstrap confidence interval ofψ 2 remains statistically insignificant. In summary, we conducted a comprehensive sensitivity analysis for the AIEDRP study considering different forms of the selection bias function and different values of the coefficients. After accounting for possible uncontrolled confounding, treatment is beneficial under a wide range of plausible scenarios, and the effect of the initiation time is insignificant.
Discussion
We have introduced a new sensitivity analysis method that uses modified G-estimators to assess the effect of possible uncontrolled confounding in longitudinal observational studies. If strong prior information is available, appropriate functional forms for the selection bias function due to unmeasured confounding can be directly imposed. We suggest varying the coefficients over a set of plausible values, which should be determined on the basis of observed data, literature, and subject matter knowledge. As we have shown through its application to HIV research, the new method can easily be adopted to provide valuable insight on the impact of uncontrolled confounding.
An extensive literature has assumed that there is one binary unmeasured confounder U , and the association of U and Y has been considered as the sensitivity parameter (see e.g. Schlesselman (1978) and Rosenbaum and Rubin (1983) ). The advantage of this approach is that the sensitivity parameter is easy to interpret; however, this approach can be restrictive, since in practice the unmeasured confounder can be of any type and can be multi-dimensional. Modeling the association of a multivariate U with Y is not straightforward. A major advantage of our approach is that it can be used to explore sensitivity to multiple unmeasured confounders simultaneously. The connection between the two approaches has not been established. In simple cases where there is one unmeasured confounder, modeling the relationship between the unmeasured confounder and the observed variables can provide insight for specifying the selection bias function and interpreting the sensitivity parameters. In the Appendix, we explore the connection between the two approaches in the context of our application to initiating ART in HIV-positive patients. In future work, we plan to evaluate and compare the performance of the two modeling approaches under various scenarios. We will also extend the work to longitudinal settings with repeated measurements, survival data, continuous treatments, and also dynamic optimal treatments.
Appendix A. Proof of Theorem 1.
First we show that
To do so, we need to show the above equation holds for both A m = 0 and 1. Consider (A1) for A m = 0,
Therefore, (A1) follows. For k > m, since
and
For l < m, since
which does not depend on A m , we have
Now we consider for l ≤ m,
where by convention t k=s X = 0 for t < s, the first equality follows from the definition of H a l, (ψ,η) , and the second equality follows from equations (2.4) and (A1), (A2) and (A3). Therefore, E(H 
where the second equality follows from (3.2). Therefore, E(G (ψ,η,q) ) = 0, proving the result.
Appendix C. Proof of Double Robustness.
where the second equality follows from (3.2) and the forth equality follows from the assumption that P r(
where the second equality follows from (3.2) and the forth equality follows from the assumption that
The left hand side of (3.5) is
where the last equality follows by applying
The right hand side of (3.5) is
where the expectations of the cross terms in the first equality are zero by the following argument. It suffices to show that for m > l,
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The approach of Schlesselman (1978) and Rosenbaum and Rubin (1983) can be used to motivate the specification of the selection bias function. Assuming that there is one unmeasured confounder U , and we have no unmeasured confounding if U is taken into account: for 0 ≤ m ≤ K, 
